AMED
Amedisys
AMED
AMED
Delisted
AMED was delisted on the 14th of August, 2025.
387 hedge funds and large institutions have $7.52B invested in Amedisys in 2021 Q1 according to their latest regulatory filings, with 45 funds opening new positions, 136 increasing their positions, 151 reducing their positions, and 50 closing their positions.
New
Increased
Maintained
Reduced
Closed
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
12% less capital invested
Capital invested by funds: $8.52B → $7.52B (-$996M)
15% less call options, than puts
Call options by funds: $33.9M | Put options by funds: $40M
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Holders
387
Holding in Top 10
1
Calls
$33.9M
Puts
$40M
Top Buyers
1 | +$93.9M | |
2 | +$69.7M | |
3 | +$61.5M | |
4 |
RP
Riverbridge Partners
Minneapolis,
Minnesota
|
+$47.3M |
5 |
BlackRock
New York
|
+$32M |
Top Sellers
1 | -$220M | |
2 | -$40.1M | |
3 | -$39.8M | |
4 |
Dimensional Fund Advisors
Austin,
Texas
|
-$38.8M |
5 |
VOYA Investment Management
Atlanta,
Georgia
|
-$30.7M |